Nature communications, Vol. 11, Issue 1, Pages 4225, 2020

PMID: 32839463

Gallbladder cancer (GBC) is an aggressive gastrointestinal malignancy with no approved targeted therapy. Here, we analyze exomes (n = 160), transcriptomes (n = 115), and low pass whole genomes (n = 146) from 167 gallbladder cancers (GBCs) from patients in Korea, India and Chile.

Read More

  https://www.ncbi.nlm.nih.gov/pubmed/32839463